ALLK logo

Allakos (ALLK) Company Overview

Profile

Full Name:

Allakos Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 19, 2018

Indexes:

Not included

Description:

Allakos Inc. operates as a clinical-stage biopharmaceutical company. The company is developing antolimab (AK002) for the treatment of eosinophilic gastritis and eosinophilic esophagitis, chronic urticaria, indolent systemic mastocytosis, and severe allergic conjunctivitis. Allakos Inc. was founded in 2012 and is headquartered in Redwood City, California.

Events Calendar

Earnings

Next earnings date:

Mar 14, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Mar 14, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Sep 26, 24 JMP Securities
Market Outperform
Jul 18, 24 Jefferies
Hold
Jun 26, 24 JMP Securities
Market Outperform
Jun 20, 24 Cantor Fitzgerald
Neutral
Jan 17, 24 Jefferies
Hold
Jan 17, 24 JMP Securities
Market Outperform
Jan 17, 24 Barclays
Underweight
Dec 18, 23 William Blair
Outperform
Nov 28, 23 JMP Securities
Market Outperform
Nov 14, 23 JMP Securities
Market Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Allakos?
  • Does Allakos pay dividends?
  • What sector is Allakos in?
  • What industry is Allakos in?
  • What country is Allakos based in?
  • When did Allakos go public?
  • Is Allakos in the S&P 500?
  • Is Allakos in the NASDAQ 100?
  • Is Allakos in the Dow Jones?
  • When was Allakos's last earnings report?
  • When does Allakos report earnings?
  • Should I buy Allakos stock now?

What is the ticker symbol for Allakos?

The ticker symbol for Allakos is NASDAQ:ALLK

Does Allakos pay dividends?

No, Allakos does not pay dividends

What sector is Allakos in?

Allakos is in the Healthcare sector

What industry is Allakos in?

Allakos is in the Biotechnology industry

What country is Allakos based in?

Allakos is headquartered in United States

When did Allakos go public?

Allakos's initial public offering (IPO) was on July 19, 2018

Is Allakos in the S&P 500?

No, Allakos is not included in the S&P 500 index

Is Allakos in the NASDAQ 100?

No, Allakos is not included in the NASDAQ 100 index

Is Allakos in the Dow Jones?

No, Allakos is not included in the Dow Jones index

When was Allakos's last earnings report?

Allakos's most recent earnings report was on Nov 6, 2024

When does Allakos report earnings?

The next expected earnings date for Allakos is Mar 14, 2025

Should I buy Allakos stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions